Ropinirole 1 mg Generic Tablets – Sun Pharmaceutical – Product Overview

Ropinirole 1 mg tablets, manufactured by Sun Pharmaceutical Industries Ltd., are supplied in unit‑dose strips containing ten immediate‑release tablets. The product is offered in pack sizes of 60, 90, and 120 tablets, allowing patients to select the quantity that best fits their treatment plan. Each strip is sealed to protect against moisture, and the tablets are film‑coated to preserve potency throughout the shelf life. Distribution occurs from authorized US facilities, with orders typically processed within one business day and shipped via standard carriers, arriving within six to fifteen days depending on the destination. This generic formulation is bioequivalent to the reference‑brand dopamine agonist, meeting the strict quality standards required by the FDA for generic drugs.

What Is Ropinirole?

Ropinirole hydrochloride is a non‑ergoline dopamine agonist that selectively stimulates D2, D3, and D4 receptors in the central nervous system. By enhancing dopaminergic activity in the basal ganglia, it compensates for the dopamine deficiency characteristic of Parkinson’s disease. In Restless Leg Syndrome, ropinirole modulates spinal sensory pathways that generate the abnormal urge to move the legs, thereby reducing discomfort and improving sleep. The generic version contains the same active ingredient as the branded product and undergoes identical manufacturing controls, ensuring comparable dissolution rates and clinical effectiveness.

Uses and Benefits

Clinicians prescribe ropinirole for two approved indications: Parkinson’s disease and Restless Leg Syndrome. In Parkinson’s disease, it improves motor symptoms such as tremor, rigidity, and bradykinesia, and can be used alone in early stages or as an adjunct to levodopa to smooth motor fluctuations. For Restless Leg Syndrome, a single daily dose taken in the evening alleviates the unpleasant leg sensations that disrupt sleep, leading to better sleep quality and reduced daytime fatigue. Clinical studies have shown that patients experience statistically significant improvements in standardized rating scales after four weeks of treatment, and real‑world data indicate higher adherence due to the simple dosing schedule.

How It Works

The pharmacologic action of ropinirole involves selective activation of dopaminergic receptors, particularly D3, which is abundant in the nigrostriatal pathway. This activation increases dopamine release and reduces the firing of inhibitory neurons, resulting in enhanced movement coordination. Unlike levodopa, ropinirole does not undergo conversion to dopamine in peripheral tissues, minimizing peripheral side effects. The drug’s onset of action occurs within one to two hours after oral administration, with peak plasma concentrations reached shortly thereafter. Because it is eliminated primarily through hepatic metabolism and has a half‑life of about five hours, dosing can be divided into multiple administrations to maintain steady therapeutic levels.

Dosage and Administration

For Parkinson’s disease, therapy typically begins with 0.25 mg taken three times daily, with gradual increments of 0.25 mg at weekly intervals as tolerated, aiming for a target dose of 1 mg three times daily. In some patients, especially those with advanced disease, daily doses up to 4 mg divided into three doses may be required, but clinicians must monitor for neuropsychiatric side effects. For Restless Leg Syndrome, the usual starting dose is 0.25 mg taken once daily in the evening; the dose may be increased to 1 mg if needed, though most patients achieve adequate symptom control at the lower dose. Tablets should be swallowed whole; crushing or chewing may alter absorption. Patients with renal impairment should have their dose reduced, with a maximum daily dose of 2 mg when creatinine clearance is below 30 mL/min.

Side Effects

Common adverse reactions include nausea, dizziness, somnolence, and constipation. Less frequent but clinically important events comprise orthostatic hypotension, hallucinations, and impulse‑control disorders such as compulsive gambling or hypersexuality. Rarely, patients may experience severe skin reactions or elevated liver enzymes, necessitating periodic laboratory monitoring in high‑risk individuals. Management of nausea often involves taking the medication with food or using a short course of antiemetics. If hallucinations or behavioral changes occur, dose reduction or discontinuation is recommended, particularly in elderly patients with pre‑existing psychiatric conditions.

Warnings and Precautions

Ropinirole is contraindicated in patients with known hypersensitivity to the drug or any of its excipients. Caution is advised in individuals with a history of psychotic disorders, as dopaminergic stimulation may exacerbate hallucinations or delusions. Concomitant use with antihypertensive medications can precipitate symptomatic hypotension, requiring regular blood pressure monitoring during dose titration. The drug should be used cautiously in patients with severe hepatic disease, as impaired metabolism may increase plasma concentrations. Pregnant or lactating women must consult a healthcare professional before use, as the medication crosses the placenta and is excreted in breast milk. Abrupt discontinuation is discouraged; a gradual taper helps prevent withdrawal symptoms and rebound parkinsonian signs.

Frequently Asked Questions

Q1: How quickly does ropinirole relieve symptoms?
A: Most patients notice improvement in motor symptoms within one to two weeks, while relief of Restless Leg discomfort often appears after a few days of nightly dosing.

Q2: Can ropinirole be taken together with levodopa?
A: Yes, it is frequently used as an adjunct to levodopa to smooth motor fluctuations, but the combination should be managed by a physician to avoid excessive dopaminergic stimulation.

Q3: Is the medication typically covered by insurance?
A: Many insurers classify ropinirole as a preferred generic, though coverage can vary; patients should verify benefits with their pharmacy benefit manager.

Q4: What should I do if I miss a dose?
A: Take the missed dose as soon as you remember, unless it is close to the time of the next scheduled dose; then skip the missed dose and resume the regular schedule.

Q5: Are there any dietary restrictions while using ropinirole?
A: No specific dietary limitations exist, but patients should avoid excessive alcohol consumption, which can increase dizziness and the risk of falls.

For detailed prescribing information, consult the FDA prescribing guide or the NIH drug database. Additional patient resources are available at Drugs.com.

Related Products

• Vortidif 20 Mg (Vortioxetine)
• Vortidif 5 Mg (Vortioxetine)
• Pramipex 0.25 mg (Pramipexole)
• Mirtaz 30 Mg (Mirtazapine)
• Lurasidone 40 mg (Generic)
• Adesam 200 mg (Ademetionine/S-Adenosyl Methionine)
• Suminat 25 mg (Sumatriptan)
• Syncapone 100 mg (Levodopa/Carbidopa/Entacapone)
• Cyclomune Eye Drop (Cyclosporin)
• Glypride 4 mg (Glimepiride)
• Natrise 15 mg (Tolvaptan)
• Simvastatin 5 mg (Simvastatin)